The list below compiled by HillCo Partners highlights key interim charges given to the House and Senate committees in regards to health care.

House Committee on Appropriations
Monitor the implementation of cost-containment initiatives in health and human services programs directed by Health and Human Services Commission Rider 51. Recommend additional opportunities for cost containment, including but not limited to, improvements in the procurement of durable medical equipment and increased medication adherence among Medicaid clients.
 
Monitor the administration of new state funding to expand behavioral health services in Texas. Make recommendations to improve coordination and prevent duplication of effort, including the behavioral health projects funded through the Medicaid 1115 waiver. Evaluate the methodology utilized by the state to fund the public mental health system in order to assess improvements in how mental health funds and associated performance targets are allocated throughout the state. Develop funding recommendations that emphasize equity in funding and performance expectations, improving outcomes, the attainment of performance targets, population needs, availability of local resources, and geographic diversity.
 
Study the implementation of provisions in SB 7 (83R) and Article II Special Provisions Section 48 regarding the Program of All-Inclusive Care for the Elderly (PACE). Make recommendations for expansion of, and improvement in, the delivery of those services if cost-effective.
 
House Committee on County Affairs
Monitor the health advisory panel stemming from HB 3793 (83R).
 
House Committee on Defense and Veterans’ Affairs
Monitor the implementation of HB 2392 (83R), Peer-to-Peer Mental Health Program, administered by the Department of Health and Human Services, particularly the interface with local mental health authorities and veterans' groups, with a focus on issues related to Post-Traumatic Stress Disorder (PTSD).
 
House Committee on Human Services
Examine crisis resources for individuals with co-occurring mental illness and intellectual/developmental disabilities. Identify strategies to serve individuals with complex behavioral and medical needs in the community.
 
Monitor and evaluate implementation of SB 7 (83R), including agency preparations for the statewide rollout of STAR+PLUS.
 
Conduct legislative oversight and monitoring of the agencies and programs under the committee’s jurisdiction, including implementation of the Balancing Incentives Program and relevant legislation passed by the 83rd Legislature. In conducting this oversight, the committee should:

a) consider any reforms to state agencies to make them more responsive to Texas taxpayers and citizens;
b) identify issues regarding the agency or its governance that may be appropriate to investigate, improve, remedy, or eliminate;
c) determine whether an agency is operating in a transparent and efficient manner; and
d) identify opportunities to streamline programs and services while maintaining the mission of the agency and its programs.

 
House Committee on Insurance
Monitor the effects of the Affordable Care Act on the availability and affordability of private health insurance coverage in Texas and on the health insurance market.
 
Evaluate options to expand transparency in the health care marketplace and facilitate informed consumer choice. Monitor the implementation of prior legislation to encourage transparency and adequacy of health care provider networks. Review prior legislative attempts to achieve greater transparency and the effectiveness of regulatory efforts to minimize the negative impacts on consumers related to out-of-network service disputes.
 
House Committee on Public Health
Assess the prevalence of nonmedical prescription drug use in the state (including opioid analgesics, stimulants, tranquilizers, and sedatives). Identify adverse health impacts. Recommend strategies to curb emerging substance abuse trends among children, pregnant women, and adults, as well as to reduce health care costs and mortality.
 
Study and make recommendations for improvements to the licensing, regulation, and monitoring of compounding pharmacies, including a review of the joint cooperative efforts between the Texas State Board of Pharmacy, Department of State Health Services, and U.S. Food and Drug Administration. Consider the impact of the passage of SB 1100 (83R), additional appropriations made by the 83rd Legislature to strengthen inspections, and any relevant federal legislation.
 
Identify strategies to support the efficient exchange of electronic health information with Texas Health and Human Services enterprise agencies. Examine legal and technical issues around the accessibility of information held in registries maintained by state agencies to authorized health care providers. Identify issues related to health information exchange and providers' liability, as well as concerns related to transitioning patient data in cases where a provider selects a new electronic health record vendor.
 
Examine the current practice for dispensation of biologic and follow-on biologic (biosimilar) pharmaceutical products in our state. Review any practices for interchangeability of drugs that might pertain to these particular medicines. Review and make recommendations regarding the substitution of biosimilar and biologic medicines.
 
Monitor transition of the state's immunization registry to a new system. Determine whether the registry can be better utilized to prevent and/or respond to communicable disease outbreaks, including pertussis. Identify potential factors contributing to the rise in the number of pertussis cases and strategies to prevent future outbreaks.
 
Conduct legislative oversight and monitoring of the agencies and programs under the committee’s jurisdiction and the implementation of relevant legislation passed by the 83rd Legislature, including HB 15 (83R). In conducting this oversight, the committee should:

a) consider any reforms to state agencies to make them more responsive to Texas taxpayers and citizens;
b) identify issues regarding the agency or its governance that may be appropriate to investigate, improve, remedy, or eliminate;
c) determine whether an agency is operating in a transparent and efficient manner; and
d) identify opportunities to streamline programs and services while maintaining the mission of the agency and its programs.

 
 
 
Senate Committee on State Affairs
Study the emerging negative impacts of the Federal Affordable Care Act, including the use of navigators, and make recommendations to mitigate any unintended consequences including rising health insurance premiums, lack of access to healthcare, mishandling of Texans' private information by insufficiently-trained navigators, and the Act’s  overall effect on Texas employers and insurance consumers. Evaluate free-market alternative to the Act, including state-led proposals to repeal, reduce or replace the Act. Closely monitor and make recommendations on the continuation of the Texas Health Insurance Pool.
 
Study and make recommendations on increasing medical price transparency in Texas, including studying the impact of SB 1731, 80th Legislative Session. Analyze relevant reforms considered or implemented in other states, and make recommendations regarding potential changes designed to create a more open marketplace for enhanced consumer decision making in Texas.
 
Senate Committee on Veteran Affairs & Military Installations
Monitor implementation of the veteran's mental health legislation passed during the 83rd Legislative Session, including funding to support the Military Veteran Peer Network at Department of State Health Services. Assess whether state mental health initiatives targeted to veterans and their families appropriately address Post Traumatic Stress Disorder. Study and make recommendations to enhance the delivery of mental health services to veterans at the local level through the network of Veteran County Service Officers.     

Senate Committee on Health & Human Services
Monitor the implementation of programs that were created or expanded by the 83rd Legislature to improve mental health and substance abuse services and assess these efforts' contribution to improved outcomes such as reduced recidivism in state hospitals, diversion from emergency rooms and county jails, and access to permanent supportive housing. Identify and address gaps in the current mental health and substance abuse system and make recommendations to better coordinate services across agencies and programs.
 
Build on previous legislative achievements in women's healthcare by examining women's access to preventative health care, pregnancy services, and post-partum care, and exploring ways to expand access and improve quality, particularly in rural and underserved areas of the state. Monitor the implementation of women's health programs in Texas. Assess these programs' impact on outcomes such as improving access to preventative services, reducing unplanned pregnancies, and achieving cost savings. Recommend ways to better coordinate the various programs in a manner that increases the number of women served, ensures adequate provider capacity statewide, and maximizes efficiencies to the state.
 
Senate Committee on Economic Development
Project and examine the costs and economic impact to Texas businesses in complying with the federal health care law. Make recommendations on options for state government intervention to reduce the negative impact of the federal health care law on Texas businesses.
 
Government Employee Health Care Plans

House Committee on Appropriations – joint charge with the House Committee on Pensions
Examine the immediate and long-term fiscal impact of the Employees Retirement System (ERS) employee health care plan. 
 
Study the affordability of health care for active public school employees. Examine how premiums and out-of-pocket costs have increased over time and how these increases have affected employees and school districts, and make appropriate recommendations. 
 
Examine the immediate and long-term fiscal impact of the Teacher Retirement System (TRS) health care plan (TRS-Care).